Frailty, inflammation, and cardiovascular disease: Evidence of a connection

被引:0
|
作者
Phan, Huy M. [2 ,4 ]
Alpert, Joseph S. [2 ]
Fain, Mindy [1 ,2 ,3 ]
机构
[1] Univ Arizona, Coll Med, Arizona Ctr Aging, Tucson, AZ 85719 USA
[2] Univ Arizona, Coll Med, Dept Med, Tucson, AZ USA
[3] Univ Arizona, Coll Med, Sect Geriatr & Gerontol, Tucson, AZ USA
[4] Univ Calif San Diego, Div Cardiol, San Diego, CA 92103 USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Frailty is a progressive physiologic decline in multiple body systems marked by loss of function, loss of physiologic reserve, and increased vulnerability to disease and death. Until recently, frailty has been poorly defined in the medical literature. One currently accepted definition of frailty is having 3 of the following 5 attributes: unintentional weight loss, muscle weakness, slow walking speed, easy exhaustion, and low physical activity. The mechanisms that underline frailty remain unclear. Significantly higher levels of markers of inflammation and the clotting cascade have been found in frail persons compared with nonfrail persons. These markers are also risk factors for the development of coronary heart disease. Recent research has indicated that frailty is a clinical manifestation of cardiovascular disease, especially of heart failure. Thus, understanding the connection between frailty and cardiovascular disease may lead to development of new interventions that will prevent and reverse the associated morbidity and mortality.
引用
收藏
页码:101 / 107
页数:7
相关论文
共 50 条
  • [1] Inflammation, Frailty and Cardiovascular Disease
    Soysal, Pinar
    Arik, Ferhat
    Smith, Lee
    Jackson, Sarah E.
    Isik, Ahmet Turan
    [J]. FRAILTY AND CARDIOVASCULAR DISEASES: RESEARCH INTO AN ELDERLY POPULATION, 2020, 1216 : 55 - 64
  • [2] Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
    Luigi Ferrucci
    Elisa Fabbri
    [J]. Nature Reviews Cardiology, 2018, 15 : 505 - 522
  • [3] Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
    Ferrucci, Luigi
    Fabbri, Elisa
    [J]. NATURE REVIEWS CARDIOLOGY, 2018, 15 (09) : 505 - 522
  • [4] Epidemiological evidence for inflammation in cardiovascular disease
    Tracy, RP
    [J]. THROMBOSIS AND HAEMOSTASIS, 1999, 82 (02) : 826 - 831
  • [5] Evidence for the Involvement of Resistin in Inflammation and Cardiovascular Disease
    Gomez-Ambrosi, Javier
    Fruehbeck, Gema
    [J]. CURRENT DIABETES REVIEWS, 2005, 1 (03) : 227 - 234
  • [6] Exploring the connection between frailty and cardiovascular diseases
    Takefuji, Yoshiyasu
    [J]. ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2024, 124
  • [7] Importance of frailty in patients with cardiovascular disease
    Singh, Mandeep
    Stewart, Ralph
    White, Harvey
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 (26) : 1726 - +
  • [8] Frailty assessment in the management of cardiovascular disease
    Wilkinson, Chris
    Rockwood, Kenneth
    [J]. HEART, 2022, 108 (24) : 1991 - 1995
  • [9] Associations of subclinical cardiovascular disease with frailty
    Newman, AB
    Gottdiener, JS
    McBurnie, MA
    Hirsch, CH
    Kop, WJ
    Tracy, R
    Walston, JD
    Fried, LP
    [J]. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2001, 56 (03): : M158 - M166
  • [10] Role of Frailty in Patients With Cardiovascular Disease
    Afilalo, Jonathan
    Karunananthan, Sathya
    Eisenberg, Mark J.
    Alexander, Karen P.
    Bergman, Howard
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (11): : 1616 - 1621